Search

Your search keyword '"Kultursay H."' showing total 97 results

Search Constraints

Start Over You searched for: Author "Kultursay H." Remove constraint Author: "Kultursay H."
97 results on '"Kultursay H."'

Search Results

1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

2. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

4. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

5. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

6. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

9. Ezetimibe added to statin therapy after acute coronary syndromes

10. Pulmonary arterial hypertension and pregnancy

11. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patient with primary hypercholesterolemia: results from the ECLIPSE study

14. Riociguat for the treatment of pulmonary arterial hypertension

15. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

16. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

18. Benefits of statin treatment in cardiac syndrome-X1

19. The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

20. The cost–effectiveness of rivaroxaban compared to enoxaparin plus adjusted-dose warfarin for the treatment of deep venous thrombosis (DVT) in Turkey

21. The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs

22. The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs

38. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study).

39. Primary spontaneous coronary artery dissections in atherosclerotic patients. Report of nine cases with review of the pertinent literature.

41. Pseudonormalization: clinical, electrocardiographic, echocardiographic, and angiographic characteristics.

42. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.

43. Antiinflammatory therapy with canakinumab for atherosclerotic disease

44. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

45. Serum Endocan Levels Predict Angiographic No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Intervention.

46. Right ventricular free-wall longitudinal speckle tracking strain in patients with pulmonary arterial hypertension under specific treatment.

47. Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.

48. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors.

49. Transcriptional profiling of septal wall of the right ventricular outflow tract in patients with idiopathic ventricular arrhythmias.

50. Increased myocardial collagen turnover in patients with progressive cardiac conduction disease.

Catalog

Books, media, physical & digital resources